search
Back to results

Efficacy of Acupuncture in Refractory Irritable Bowel Syndrome

Primary Purpose

Irritable Bowel Syndrome

Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Acupuncture
Sponsored by
Chengdu University of Traditional Chinese Medicine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Irritable Bowel Syndrome

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adults aged 18-70 years (either sex);
  • Fulfilled Rome IV criteria for IBS;
  • Patients with normal occult blood in stool in recent one month;
  • The age is above 50, the results of colonoscopy are normal in near year;
  • Symptoms are present for ≥12 months;
  • There is an absence of response to a minimum of 6 weeks of dietary intervention or advice;
  • There is an absence of response to an adequate dose of at least one conventional pharmacological agent tried for a minimum of 6 weeks;
  • Signed the written informed consent form.

Exclusion Criteria:

  • Previous colonoscopy, meal barium fluoroscopy, abdominal ultrasound and other examinations found severe intestinal organic lesions (including but not limited to ulcerative colitis, familial multiple intestinal polyps, colorectal cancer patients);
  • The presence of one or more of the following warning symptoms: unexplained rectal bleeding, a positive faecal occult blood test result; anaemia, abdominal mass, ascites, fever, and emaciation;
  • The presence of other severe medical conditions, such as cardiovascular disease, endocrine disorders, hepatic dysfunction, renal diseases, and cognitive disorders that can affect the outcome assessment results;
  • Unconscious, unable to express subjective symptoms of discomfort and clearly diagnosed severe mental disorders;
  • An unstable psychological state or accompanying psychological disorders (SDS>56);
  • With pregnancy or lactation;
  • Accepting acupuncture treatment in the last 3 months;
  • Difficulties in attending the trial, such as fear of acupuncture.

Sites / Locations

  • Hospital of Chengdu University of Traditional Chinese MedicineRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

Acupuncture plus usual care

Sham acupuncture plus usual care

Arm Description

Acupuncture will be given on the basis of usual care. A total of 12 sessions of acupuncture will be given over a period of 4 weeks.

Sham acupuncture refers to acupuncture at sham points. Sham acupuncture will be given on the basis of usual care. A total of 12 sessions of sham acupuncture will be given over a period of 4 weeks.

Outcomes

Primary Outcome Measures

The proportion of participants with adequate relief of global IBS symptoms
Adequate relief of global IBS symptoms will be defined as a >50% reduction in the IBS symptom severity scale (IBS-SSS).

Secondary Outcome Measures

IBS symptom severity scale
The IBS symptom severity scale (IBS-SSS) has a total of 500 points. The score ranges from 0 to 500; higher scores indicating more severe symptoms; a score over 300 indicates severe symptoms.
Weekly bowel movements
The total number of bowel movements in a week.
Work and Social Adjustment Scale
The Work and Social Adjustment Scale (WSAS) measures the effect of IBS on ability to work and manage at home, participate in social and private leisure activities and maintain relationships. It has five domains scored 0 (not affected) to 8 (severely affected), with a total possible score of 40.
Irritable Bowel Syndrome Quality of Life Instrument
Irritable Bowel Syndrome Quality of Life Instrument (IBS-QOL) is a condition-specific measure for assessing health-related QoL among persons with irritable bowel syndrome. The IBS-QOL had eight subscales. The IBS-QOL and its subscales were both scored on a range of 0-100 with higher scores suggestive of better QOL.
Bristol Stool Form Scale
The Bristol Stool Form Scale is a tool that is used for the assessment of stool consistency. Scores 1-2 indicate constipation, scores 3-5 indicate normal stool; scores 6-7 indicate diarrhea.
Self-Rating Anxiety Scale (SAS)
The SAS is a self rating scale for the assessment of the severity of anxiety.
Self-Rating Depression Scale (SDS)
The SDS is a self rating scale for the assessment of the severity of depression.

Full Information

First Posted
February 14, 2020
Last Updated
May 6, 2021
Sponsor
Chengdu University of Traditional Chinese Medicine
Collaborators
Beijing University of Chinese Medicine
search

1. Study Identification

Unique Protocol Identification Number
NCT04276961
Brief Title
Efficacy of Acupuncture in Refractory Irritable Bowel Syndrome
Official Title
Acupuncture in Addition to Usual Care for the Treatment of Refractory Irritable Bowel Syndrome: a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
May 2021
Overall Recruitment Status
Unknown status
Study Start Date
October 15, 2020 (Actual)
Primary Completion Date
June 1, 2021 (Anticipated)
Study Completion Date
June 1, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Chengdu University of Traditional Chinese Medicine
Collaborators
Beijing University of Chinese Medicine

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The trial aims to examine the efficacy and safety of acupuncture in the treatment of refractory irritable bowel syndrome (IBS). The investigators will include 170 participants to receive acupuncture plus usual care or sham acupuncture plus usual care. Twelve sessions of acupuncture will be delivered to participants over a period of 4 weeks. The primary outcome is defined as proportion of participants with adequate relief of global IBS symptoms at week 8, which is defined as >50% reduction in IBS-SSS scale.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Irritable Bowel Syndrome

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
170 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Acupuncture plus usual care
Arm Type
Experimental
Arm Description
Acupuncture will be given on the basis of usual care. A total of 12 sessions of acupuncture will be given over a period of 4 weeks.
Arm Title
Sham acupuncture plus usual care
Arm Type
Sham Comparator
Arm Description
Sham acupuncture refers to acupuncture at sham points. Sham acupuncture will be given on the basis of usual care. A total of 12 sessions of sham acupuncture will be given over a period of 4 weeks.
Intervention Type
Other
Intervention Name(s)
Acupuncture
Intervention Description
Acupuncture will be given for a total of 12 session over 4 weeks. Acupuncture at acupoints Tianshu (ST25), Shangjuxu (ST37), Zusanli (ST36), and Neiguan (PC6) bilaterally will be given.
Primary Outcome Measure Information:
Title
The proportion of participants with adequate relief of global IBS symptoms
Description
Adequate relief of global IBS symptoms will be defined as a >50% reduction in the IBS symptom severity scale (IBS-SSS).
Time Frame
4 weeks after randomization (week 4)
Secondary Outcome Measure Information:
Title
IBS symptom severity scale
Description
The IBS symptom severity scale (IBS-SSS) has a total of 500 points. The score ranges from 0 to 500; higher scores indicating more severe symptoms; a score over 300 indicates severe symptoms.
Time Frame
Baseline (week 0), week 2, 4, 6, 8
Title
Weekly bowel movements
Description
The total number of bowel movements in a week.
Time Frame
Baseline (week 0), week 2, 4, 6, 8
Title
Work and Social Adjustment Scale
Description
The Work and Social Adjustment Scale (WSAS) measures the effect of IBS on ability to work and manage at home, participate in social and private leisure activities and maintain relationships. It has five domains scored 0 (not affected) to 8 (severely affected), with a total possible score of 40.
Time Frame
Baseline (week 0), week 2, 4, 6, 8
Title
Irritable Bowel Syndrome Quality of Life Instrument
Description
Irritable Bowel Syndrome Quality of Life Instrument (IBS-QOL) is a condition-specific measure for assessing health-related QoL among persons with irritable bowel syndrome. The IBS-QOL had eight subscales. The IBS-QOL and its subscales were both scored on a range of 0-100 with higher scores suggestive of better QOL.
Time Frame
Baseline (week 0), week12, and month12
Title
Bristol Stool Form Scale
Description
The Bristol Stool Form Scale is a tool that is used for the assessment of stool consistency. Scores 1-2 indicate constipation, scores 3-5 indicate normal stool; scores 6-7 indicate diarrhea.
Time Frame
Baseline, weeks 2, 4, 6 and 8.
Title
Self-Rating Anxiety Scale (SAS)
Description
The SAS is a self rating scale for the assessment of the severity of anxiety.
Time Frame
Baseline, weeks 2, 4.
Title
Self-Rating Depression Scale (SDS)
Description
The SDS is a self rating scale for the assessment of the severity of depression.
Time Frame
Baseline, weeks 2, 4.
Other Pre-specified Outcome Measures:
Title
Proportion of participants with adverse events
Description
Side effect of acupuncture or sham acupuncture will be recorded.
Time Frame
Week 4 and 12

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adults aged 18-70 years (either sex); Fulfilled Rome IV criteria for IBS; Patients with normal occult blood in stool in recent one month; The age is above 50, the results of colonoscopy are normal in near year; Symptoms are present for ≥12 months; There is an absence of response to a minimum of 6 weeks of dietary intervention or advice; There is an absence of response to an adequate dose of at least one conventional pharmacological agent tried for a minimum of 6 weeks; Signed the written informed consent form. Exclusion Criteria: Previous colonoscopy, meal barium fluoroscopy, abdominal ultrasound and other examinations found severe intestinal organic lesions (including but not limited to ulcerative colitis, familial multiple intestinal polyps, colorectal cancer patients); The presence of one or more of the following warning symptoms: unexplained rectal bleeding, a positive faecal occult blood test result; anaemia, abdominal mass, ascites, fever, and emaciation; The presence of other severe medical conditions, such as cardiovascular disease, endocrine disorders, hepatic dysfunction, renal diseases, and cognitive disorders that can affect the outcome assessment results; Unconscious, unable to express subjective symptoms of discomfort and clearly diagnosed severe mental disorders; An unstable psychological state or accompanying psychological disorders (SDS>56); With pregnancy or lactation; Accepting acupuncture treatment in the last 3 months; Difficulties in attending the trial, such as fear of acupuncture.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Min Chen, MD, PhD
Phone
028-87765705
Email
cm@cdutcm.edu.cn
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Zhi-Gang Li, MD
Organizational Affiliation
Beijing University of Chinese Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital of Chengdu University of Traditional Chinese Medicine
City
Chengdu
State/Province
Sichuan
ZIP/Postal Code
610075
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hui Zheng
Phone
+862887689918
Email
zhenghui@cdutcm.edu.cn

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Conditional share, the principle investigator will ask for the reasons to use the data.
IPD Sharing Time Frame
After the completing the study for 2 years
Citations:
PubMed Identifier
34518248
Citation
Zhao J, Chen M, Wang X, Ye K, Shi S, Li H, Wang J, Chen X, Ni J, Wei Q, Shi Y, Hu Y, Sun J, Li D, Liu S, Li Z, Zheng H, Yu SG. Efficacy of acupuncture in refractory irritable bowel syndrome: study protocol for a randomised controlled trial. BMJ Open. 2021 Sep 13;11(9):e045655. doi: 10.1136/bmjopen-2020-045655.
Results Reference
derived

Learn more about this trial

Efficacy of Acupuncture in Refractory Irritable Bowel Syndrome

We'll reach out to this number within 24 hrs